Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use (GSPE)

This study has been completed.
Sponsor:
Collaborator:
National Natural Science Foundation of China
Information provided by (Responsible Party):
Jie Qiu, Shandong University
ClinicalTrials.gov Identifier:
NCT01707615
First received: August 14, 2012
Last updated: October 14, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2011
  Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)